当前位置:首页 - 行情中心 - 特一药业(002728) - 财务分析 - 现金流量表

特一药业

(002728)

  

流通市值:45.07亿  总市值:46.15亿
流通股本:5.01亿   总股本:5.13亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金625,312,404.92459,424,569.14205,543,757.02982,118,788.89
  收到的税费返还---3,116,430.55
  收到其他与经营活动有关的现金4,156,291.113,241,348.512,822,691.238,506,168.56
  经营活动现金流入小计629,468,696.03462,665,917.65208,366,448.25993,741,388
  购买商品、接受劳务支付的现金199,031,170.08141,390,065.0665,400,700.02231,852,321.31
  支付给职工以及为职工支付的现金95,393,800.4864,092,153.5434,161,178.09114,578,720.76
  支付的各项税费39,256,136.929,243,884.9720,125,433.2791,280,757.53
  支付其他与经营活动有关的现金228,646,142.47142,548,976.9477,003,958.3311,941,045.21
  经营活动现金流出小计562,327,249.93377,275,080.51196,691,269.68749,652,844.81
  经营活动产生的现金流量净额67,141,446.185,390,837.1411,675,178.57244,088,543.19
二、投资活动产生的现金流量:
  取得投资收益收到的现金2,749,820.282,062,457.521,398,476.22795,560.28
  处置固定资产、无形资产和其他长期资产收回的现金净额1,000800800200,800
  收到的其他与投资活动有关的现金1,104,988,000766,996,000299,998,000195,000,000
  投资活动现金流入小计1,107,738,820.28769,059,257.52301,397,276.22195,996,360.28
  购建固定资产、无形资产和其他长期资产支付的现金47,990,170.0731,265,590.0613,448,694.9479,547,293.79
  支付其他与投资活动有关的现金1,072,487,000729,996,000314,998,000405,000,000
  投资活动现金流出小计1,120,477,170.07761,261,590.06328,446,694.94484,547,293.79
  投资活动产生的现金流量净额-12,738,349.797,797,667.46-27,049,418.72-288,550,933.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金---15,436,169.05
  取得借款收到的现金560,000,000410,000,00080,000,000618,950,602.65
  收到其他与筹资活动有关的现金82,271,31082,271,310-184,000,000
  筹资活动现金流入小计642,271,310492,271,31080,000,000818,386,771.7
  偿还债务支付的现金430,000,000250,000,00050,000,000889,000,000
  分配股利、利润或偿付利息支付的现金78,683,666.3578,252,885.18405,704.224,913,403.99
  支付其他与筹资活动有关的现金---37,336,006.47
  筹资活动现金流出小计508,683,666.35328,252,885.1850,405,704.2951,249,410.46
  筹资活动产生的现金流量净额133,587,643.65164,018,424.8229,594,295.8-132,862,638.76
五、现金及现金等价物净增加额187,990,739.96257,206,929.4214,220,055.65-177,325,029.08
  加:期初现金及现金等价物余额125,636,694.41125,636,694.41125,636,694.41302,961,723.49
  期末现金及现金等价物余额313,627,434.37382,843,623.83139,856,750.06125,636,694.41
补充资料:
  净利润-31,108,115.76-81,671,615.4
  资产减值准备--938,933.55--305,798.2
  固定资产和投资性房地产折旧-30,318,262.15-56,271,060.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-30,318,262.15-56,271,060.28
  无形资产摊销-7,042,588.06-13,549,376.71
  处置固定资产、无形资产和其他长期资产的损失--802.85-68,451.01
  固定资产报废损失---818,804.44
  财务费用-2,011,538.68-3,770,236.12
  投资损失--2,062,457.52--795,560.28
  递延所得税-6,642,079.5--7,914,019.29
  其中:递延所得税资产减少-6,749,620.38--6,916,229.01
    递延所得税负债增加--107,540.88--997,790.28
  存货的减少--32,283,233.67-25,090,917.51
  经营性应收项目的减少-105,031,380.73-45,813,227.51
  经营性应付项目的增加--63,340,060.82-25,885,218.28
  其他-1,862,360.67-165,013.7
  现金的期末余额-382,843,623.83-125,636,694.41
  减:现金的期初余额-125,636,694.41-302,961,723.49
  现金及现金等价物的净增加额-257,206,929.42--177,325,029.08
公告日期2026-10-272026-08-212026-04-282026-03-24
审计意见(境内)标准无保留意见
TOP↑